Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts

Pharmacology

Volumn 61, Issue 4, 2000, Pages 238-243

  Hayashi, Yukio ^a   Tajima, Kiyotaka ^a   Kirimoto, Tsukasa ^a   Miyake, Hidekazu ^a   Matsuura, Naosuke ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cardioprotection; Ischemia reperfusion; Long chain acylcarnitine; MET 88; Rat working heart; Butyrobetaine hydroxylase inhibitor

Indexed keywords

CARNITINE; GAMMA BUTYROBETAINE; MILDRONATE; NIFEDIPINE; OXYGENASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FATTY ACID METABOLISM; HEART DISEASE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0033652408     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028407     Document Type: Article

References (24)

1. Role of carnitine in fatty acid metabolism of normal and ischemic myocardium
2. Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium
3. Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats
4. +)-ATPase of cardiac sarcolemma: A possible role in myocardial ischemia
5. Inhibition of gap junctional conducatance by long-chain acylcarnitines and their preferential accumulation in junctional sarcolemma during hypoxia
6. Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia
7. Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: Role of endogenous long-chain acylcarnitine
8. 3-(2,2,2-Trimethylhydrazinium)propionate (THP) - A novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties
9. Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts
10. Reduction in carnitine content by inhibition of its biosynthesis results in protection of isolated guinea pig hearts against hypoxic damage
11. Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts
12. Effects of ischemia on function and metabolism of the isolated working rat heart
13. Effect of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart
14. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart
15. Effects of nifedipine on global myocardial ischemic injury in hearts from diabetic and age-matched control rats
16. Comparative anti-ischemic effects of dihydropyridine calcium antagonists in isolated perfused rat hearts: Relationship of cardiodepression and cardioprotection
17. Effects of diltiazem and propranolol on irreversibility of ischemic cardiac function and metabolism in the isolated perfused rat heart
18. Beneficial effects of MET-88 on left ventricular dysfunction and hypertrophy with volume overload in rats
19. Effect of 3-(2,2,2-Trimethylhydrazinium)propionate, gamma-butyrobetaine hydroxylase inhibitor, on isoproterenol-induced mitochondrial dysfunction
20. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts
21. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine
22. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, etomoxir
23. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium